Journal article
Association between Menopausal Hormone Therapy and Incidence of Psoriasis: A Secondary Analysis from the Women's Health Initiative Randomized Clinical Trials
British journal of dermatology (1951), Vol.185(3), pp.669-671
04/29/2021
DOI: 10.1111/bjd.20410
PMID: 33913153
Abstract
Estrogen level fluctuations have been linked to psoriasis (1); however, the association between menopausal hormone therapy and risk of psoriasis is largely unexplored. We analyzed data from the Women's Health Initiative's (WHI) randomized controlled trials comparing conjugated equine estrogens (CEE) vs. placebo and CEE plus medroxyprogesterone acetate (MPA) vs. placebo to investigate the association between hormone therapy use and psoriasis.
Details
- Title: Subtitle
- Association between Menopausal Hormone Therapy and Incidence of Psoriasis: A Secondary Analysis from the Women's Health Initiative Randomized Clinical Trials
- Creators
- A A Chan - Department of Medicine, Division of Dermatology, The Lundquist Institute, Torrance, CA, 90503, USAJ Noguti - The Lundquist InstituteC T Yang - Boston UniversityS R Feldman - Wake Forest UniversityR B Wallace - University of IowaA H Shadyab - University of California SystemJ E Manson - Brigham and Women's HospitalA K Aragaki - Fred Hutch Cancer CenterR T Chlebowski - Department of Medicine, Division of Hematology/Oncology, The Lundquist Institute, Torrance, CA, 90503, USA.D J Lee - Department of Medicine, Division of Dermatology, The Lundquist Institute, Torrance, CA, 90503, USA
- Resource Type
- Journal article
- Publication Details
- British journal of dermatology (1951), Vol.185(3), pp.669-671
- DOI
- 10.1111/bjd.20410
- PMID
- 33913153
- NLM abbreviation
- Br J Dermatol
- ISSN
- 0007-0963
- eISSN
- 1365-2133
- Language
- English
- Date published
- 04/29/2021
- Academic Unit
- Epidemiology; Injury Prevention Research Center; Internal Medicine
- Record Identifier
- 9984364404702771
Metrics
19 Record Views